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ABSTRACT
Objectives To examine the relation between area level
social deprivation and ultrasound markers of
atherosclerosis (common carotid intima-media thickness
and plaque score), and to determine whether any
differences can be explained by “classic” (currently
recognised) or “emerging” (novel) cardiovascular risk
factors.
Design Cross sectional, population based study.
Setting NHS Greater Glasgow Health Board area.
Participants 666 participants were selected on the basis
of how their area ranked in the Scottish Index of Multiple
Deprivation 2004. Approximately equal numbers of
participants from the most deprived areas and the least
deprived areas were included, as well as equal numbers
of men and women and equal numbers of participants
from each age group studied (35-44, 45-54, and
55-64 years).
Main outcome measures Carotid intima-media thickness
and plaque score, as detected by ultrasound.
Results The mean age and sex adjusted intima-media
thickness was significantly higher in participants from the
most deprived areas than in those from the least deprived
areas (0.70 mm (standard deviation (SD) 0.16 mm) v
0.68 mm (SD 0.12 mm); P=0.015). On subgroup analysis,
however, this difference was only apparent in the highest
age tertile in men (56.3-66.5 years). The difference in
unadjusted mean plaque score between participants
from themost deprived and those from the least deprived
areas was more striking than the difference in intima-
media thickness (least deprived 1.0 (SD 1.5) vmost
deprived 1.7 (SD2.0); P<0.0001). In addition, a significant
difference in plaque score was apparent in the two
highest age tertiles in men (46.8-56.2 years and 56.3-66.
5 years; P=0.0073 and P<0.001) and the highest age
tertile in women (56.3-66.5 years; P<0.001). The
difference in intima-media thickness between most
deprived and least deprived males remained significant
after adjustment for classic risk factors, emerging risk
factors, and individual level markers of socioeconomic
status (P=0.010). Adjustment for classic risk factors and
emerging cardiovascular risk factors, either alone or in
combination, did not abolish the deprivation based
difference in plaque presence (as a binary measure;
adjusted odds ratio of 1.73, 95% confidence interval 1.07
to 2.82). However, adjustment for classic risk factors and
individual levelmarkers of early life socioeconomic status
abolished the difference in plaque presence between the
most deprived and the least deprived individuals
(adjusted odds ratio 0.94, 95% CI 0.54 to 1.65; P=0.84).
Conclusions Deprivation is associated with increased
carotid plaque score and intima-media thickness. The
association of deprivation with atherosclerosis is
multifactorial and not adequately explained by classic or
emerging risk factors.
INTRODUCTION
Ill health has long been recognised as more prevalent
in areas of relative social deprivation,1-5 as exemplified
by the higher incidence of coronary heart disease in
areas of socioeconomic deprivation compared with
socioeconomically advantaged areas.6-8 Although
“classic” (currently recognised) risk factors go some
way toward explaining this gradient,9 they do not
explain all the difference.10 11 This point was demon-
strated by a 25 year follow-up of civil servants in the
firstWhitehall study, which showed that only one third
of the differences in mortality between employment
grades could be explained by differences in choles-
terol, smoking, systolic blood pressure, impaired glu-
cose tolerance, and diabetes.12 In recent years, novel
biomarkers associated with insulin resistance, inflam-
mation, and endothelial dysfunction have emerged as
potential cardiovascular risk factors.13 However,
whether any of these markers helps explain the socio-
economic gradient in coronary heart disease remains
to be seen.
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Carotid ultrasound is an efficient validated tool for
assessing the degree of atherosclerosis in an individual.
Measurement of the artery wall intima-media thick-
ness is a commonly used index of atherosclerosis. A
recent systematic review and meta-analysis showed
that the age and sex adjusted relative risk for myo-
cardial infarction increases by 1.15 (95% confidence
interval 1.12 to 1.17) for every 0.10 mm increase in
carotid intima-media thickness.14 The adjusted relative
risk for stroke increases by 1.18 (95% CI 1.16 to 1.21)
for every 0.10 mm increase in carotid intima-media
thickness.
Ultrasound detection of carotid plaques is also
highly informative.15 Plaque score has been shown to
be associatedwith risk ofmyocardial infarction16-18 and
stroke.19 In the Rotterdam study, the hazard ratio for
myocardial infarction for a plaque score of three or
more compared with one of zero was 1.83 (95% CI
1.27 to 2.62),16 and the age and sex adjusted relative
risk for stroke was 1.61 (95% CI 1.16 to 2.23) for the
highest tertile of plaque score compared with the low-
est tertile.19
Given current understanding of the process of ather-
ogenesis, carotid plaque presence is a more mechanis-
tically plausible marker of atherosclerosis than is
carotid intima-media thickness. Previous studies have
suggested that plaque presence is indeedmore strongly
predictive of future cardiovascular events—specifi-
cally acute myocardial infarction—than intima-media
thickness.20 21 The American Society of Echocardio-
graphy has recognised a clinical role for measurement
of intima-media thickness and detection of plaques in
refining cardiovascular risk assessment in asympto-
matic patients assessed as being at intermediate cardio-
vascular risk.22
Several studies have examined the relation between
socioeconomic status and ultrasoundmarkers of ather-
osclerosis. Most studies have examined individual
level measures of socioeconomic position (for exam-
ple, income, education, occupation, housing tenure)
and their relation to carotid intima-media
thickness.23-29 Rosvall et al, however, studied a popula-
tion based sample of 4033 individuals and found sig-
nificant associations between area level deprivation
and carotid plaque score.30 These associations were
only slightly reduced on adjusting for individual level
markers of socioeconomic position. Similarly, a study
in Pittsburgh, Pennsylvania, found associations
between community level socioeconomic status and
both carotid intima-media thickness and carotid
plaque occurrence.31 The association with plaque
occurrence persisted after adjusting for individual
level markers of socioeconomic status.
Glasgow, Scotland, provides an ideal setting for
detailed investigation into associations between social
deprivation and cardiovascular disease. At community
level (the level of primary care localities, each with an
average population of 70 000 people), life expectancy
at birth formen is 63.5 years in themost deprived parts
of the city and 78.7 years in the least deprived areas. At
postcode sector level (average population 3000-5000
individuals), the difference in life expectancy for men
betweenmost and least deprived groups is 28.7 years.32
The aim of this study was to enhance our under-
standingof the factors underlying associationsbetween
deprivation and ill health, with particular emphasis on
atherosclerosis.Wemeasured a wide range of “classic”
and “emerging” cardiovascular risk factors,with a view
to examining variables that could potentially explain
the difference in prevalence of cardiovascular disease
between most and least deprived populations. Our
hypothesis was that social deprivation would be asso-
ciated with higher common carotid intima-media
thickness and/or plaque score, but that adjustment
for emerging risk factors, especially inflammatorymar-
kers, would account for such differences.
METHODS
Study population
The design of the psychological, social, and biological
determinants of ill health (pSoBid) study—including
recruitment strategy, response rates, and study proto-
col—has been described in detail elsewhere.33 Selec-
tion of participants was based on the Scottish Index
of Multiple Deprivation 2004,34 which ranks small
areas on the basis of multiple deprivation indicators
across six domains, namely: income; employment;
health; education, skills, and training; geographic
access and telecommunications; and housing. The
measures in the Scottish IndexofMultipleDeprivation
permit identification of the least and most deprived
areas in the NHSGreater GlasgowHealth Board area.
Five general practices with the highest percentage of
patients aged 35-64 years living in areas classified as
being in the bottom 5% of all areas classed by the Scot-
tish Index of Multiple Deprivation (that is, the most
deprived areas) were approached, and all agreed to
participate in the recruitment process. A further five
practices with the highest percentage of patients aged
35-64 years living in areas classified as being in the top
20%of the Scottish Index ofMultipleDeprivation (that
is, the least deprived areas) also agreed to participate.
The health information and technology section of
NHS Greater Glasgow Health Board generated a tar-
get population of 21 672 people from the lists of these
10 practices. From this target population, 12 groups of
300 participants were selected according to strata
defined by the combination of home address, Scottish
Index of Multiple Deprivation classification, gender,
and age group (35-44, 45-54, and 55-64 years). The
total sampling frame comprised 3600 participants.
The sampling frame was constructed from general
practice lists and, therefore, included individuals
regardless ofwhether they actually visited their general
practitioner. As the study progressed, oversampling of
themost deprived groupwas required owing to a lower
response rate. The health information technology sec-
tion was approached to randomly select further poten-
tial participants from the target population. We
recruited approximately equal numbers from the
most and the least deprived areas, equal numbers of
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men and women, and equal numbers from each age
group studied.
Study protocol
Participant visits were conducted between December
2005 and May 2007, with participants attending for
two visits generally about two weeks apart. In visit
one, participants completed lifestyle and psychology
questionnaires and underwent measurement of blood
pressure; heart rate; hip, waist, and mid-thigh circum-
ference; and lung function.
For visit two, participants undertook a 10-12 hour fast
and subsequently provided blood samples for biochem-
ical analyses. All blood samples were separated and fro-
zen at −80°C within 1 hour of venepuncture. The
exceptionwas samples tobe tested for cholesterol, trigly-
cerides, low density lipoprotein, high density lipopro-
tein, apolipoproteins A1 and B, C reactive protein, and
glucose, which were analysed on fresh plasma.
Height and weight were also measured at visit two.
After being provided with breakfast, participants com-
pleted psychological and cognitive tests. Finally, caro-
tid ultrasound was performed.
All scans were performed on an ACUSON Sequoia
512 Ultrasound System with an L7 5-12 MHz linear
array broadband transducer (Siemens Medical Solu-
tions, Erlangen, Germany). The majority of the scans
were performed by the same research nurse, who was
trained in ultrasound techniques at the Department of
Vascular Medicine, Academic Medical Centre,
Amsterdam, The Netherlands. As prespecified in the
study protocol, research nurses performing ultrasono-
graphy were required to complete a minimum of 10
paired replicate volunteer scans before scanning parti-
cipants. Quality of images and reproducibility of
intima-media thickness measurements from paired
scans were assessed by the Department of Vascular
Medicine. Research nurses had to meet predefined
reproducibility criteria to be permitted to carry out
study scans. Further paired replicate scans of volun-
teers were performed at intervals throughout the
study to demonstrate continued fulfilment of the qual-
ity criteria.
Both left and right carotid arteries were assessed.
The protocol involved initially measuring Doppler
velocity in the internal carotid artery to exclude signif-
icant stenosis. Thereafter, B mode still images and
dynamic clips were recorded of the distal 1 cm of the
common carotid artery, the carotid bulb, and the prox-
imal internal carotid artery on both sides. Finally, anM
mode image of wall movement in the distal 1 cm of the
common carotid artery was recorded over at least two
cardiac cycles to allow assessment of arterial stiffness.
Each scanwas saved as aDigital Imaging andCommu-
nications in Medicine file.
Scans were analysed using the eTrack software pro-
vided by the Department of Vascular Medicine and
Physiology, Academic Medical Centre, Amsterdam,
The Netherlands. All scans were analysed by the
same reader, who was blinded to the identities of the
participants. Reader reproducibility was assessed by
repeat reading of a proportion of the scans. Repeat
reads were consistently within the predefined certifica-
tion limits of a coefficient of variation of ≤5%.
Outcome measures
Theprespecified primary outcomewasmean common
carotid intima-media thickness. Intima-media thick-
ness was measured on the far wall of each arterial seg-
ment, averaged along a 1 cm length or as much as was
able to be read. The secondary outcome was plaque
score,16 which was determined by counting the num-
ber of plaques. A plaque was defined as a focal struc-
ture encroaching into the arterial lumen by at least
0.5 mm or by 50% of the surrounding intima-media
thickness, or demonstrating a thickness >1.5 mm
as measured from media-adventitia interface to
intima-lumen interface.15 Plaque count was then
converted into a plaque score by dividing this value
by the number of readable images present and multi-
plying the outcome by 6 (the maximum possible
number of images per participant),16 thus adjusting
for unreadable images.
Analysis of risk factors
Circulating markers
Classic risk factors—Cholesterol and triglyceride
concentrations were determined by enzymatic colori-
metric assays on a Roche Hitachi 917 analyser (Roche
Diagnostics Ltd, Burgess Hill, UK). Lipid fractions
weremeasuredusing ultracentrifugation andprecipita-
tion methods.35 Glucose was measured by hexokinase
and glucose-6-phosphate dehydrogenase assay on an
Abbott c8000 analyser (Abbott Diagnostics, Maiden-
head, UK).
Emerging risk factors—Insulin and adiponectin
were measured by sandwich enzyme linked immuno-
sorbent assay (Mercodia AB, Uppsala, Sweden and
ALPCO Diagnostics, Salem, NH, USA, respectively).
Leptin was measured by an in-house radio-
immunoassay validated against a commercially avail-
able radioimmunoassay (LincoResearch Inc, St Louis,
MO, USA) .36 High sensitivity C reactive protein was
measured by an immunoturbidimetric assay (Roche
Diagnostics Ltd). Interleukin 6 and intercellular adhe-
sion molecule 1 were measured by sandwich enzyme
linked immunosorbent assay (R&D Systems Europe
Ltd, Abingdon, UK). von Willebrand factor was mea-
sured using an in-house enzyme linked immunosor-
bent assay, employing rabbit anti-human polyclonal
antibodies (DAKO UK Ltd, Ely, UK). Fibrinogen
was measured on an automated coagulometer (MDA-
180; Organon Teknika, Cambridge, UK). D-dimer
and tissue plasminogen activator antigen were mea-
sured by enzyme linked immunosorbent assay
(Hyphen, Neuville-sur-Oise, France).
Physical activity
Questions on habitual physical activity at work and in
recreation were included in the lifestyle questionnaire,
RESEARCH
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Table 1 | Characteristics of study participants
Least deprived
(n=342)
Most deprived
(n=324)
Least minus most deprived
(adjusted for age and sex(95% CI)) P value
Markers of individual socioeconomic status
Height (cm) 171.0 (9.4) 165.0 (8.7) 5.72 (4.77 to 6.66) <0.0001
Data missing 2 (0) 1 (0)
Leg length (cm) 81.9 (6.0) 78.7 (5.4) 3.07 (2.31 to 3.83) <0.0001
Data missing 41 (0) 21 (0)
People per room at age 11 years 1.2 (0.5) 1.8 (0.9) −0.67 (−0.78 to −0.56) <0.0001
Data missing 0 (0) 2 (0)
Father’s Registrar General social class <0.0001
0 Data not classifiable 15 (4%) 17 (5%)
I Professional 30 (9%) 1 (0.3%)
II Managerial & technical 130 (38%) 27 (8%)
IIIN Skilled non-manual 30 (9%) 13 (4%)
IIIM Skilled manual 98 (29%) 155 (48%)
IV Partly skilled 22 (7%) 43 (13%)
V Unskilled 10 (3%) 42 (13%)
Unknown to participant 4 (1%) 16 (5%)
Unemployed 1 (0.3%) 10 (3%)
Data missing 2 (0) 0 (0)
Participant’s Registrar General social class <0.0001
0 Data not classifiable 1 (0.3%) 16 (5%)
I Professional 58 (17%) 5 (2%)
II Managerial & technical 193 (57%) 57 (18%)
IIIN Skilled non-manual 59 (17%) 52 (16%)
IIIM Skilled manual 16 (5%) 87 (27%)
IV Partly skilled 10 (3%) 70 (22%)
V Unskilled 2 (0.6%) 35 (11%)
Unemployed 1 (0.3%) 2 (0.6%)
Data missing 2 (0) 0 (0)
Annual household income <0.0001
<£15 000 12 (4%) 186 (57%)
£16-25 000 29 (9%) 78 (24%)
£26-35 000 40 (12%) 21 (7%)
£36-45 000 44 (13%) 13 (4%)
>£45 000 187 (55%) 10 (3%)
Data missing 30 (0) 16 (0)
Total education (years) 16.1 (3.6) 11.8 (2.5) 4.32 (3.85 to 4.79) <0.0001
Data missing 0 (0) 0 (0)
Classic risk factors (behavioural)
Smoking
Ever smoked regularly 121 (35.4%) 241 (74.4%) 12.07 (7.33 to 19.88)† <0.0001
Current cigarette smoker 21 (6.1%) 131 (40.4%)
Data missing 0 (0) 0 (0)
Physical activity <0.0001
Inactive 82 (24%) 160 (49%)
Moderately inactive 84 (25%) 37 (11%)
Moderately active 87 (25%) 71 (22%)
Active 89 (26%) 56 (17%)
Data missing 0 (0) 0 (0)
Classic risk factors (physiological)
Cholesterol (mmol/l) 5.29 (1.03) 4.95 (1.05) 0.35 (0.19 to 0.51) <0.0001
Data missing 7 (0) 14 (0)
Triglycerides (mmol/l) 1.19 1.44 −0.20 (−0.27 to −0.12)‡ <0.0001
Data missing 7 (0) 14 (0)
Low density lipoprotein cholesterol (mmol/l) 3.16 (0.87) 2.86 (0.88) 0.31 (0.17 to 0.44) <0.0001
Data missing 7 (0) 18 (0)
High density lipoprotein cholesterol (mmol/l) 1.43 (0.38) 1.30 (0.39) 0.13 (0.08 to 0.19) <0.0001
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allowing participants to be classified as inactive, mod-
erately inactive, moderately active, or active using a
previously validated protocol.37
Statistical analysis
The size of the sample required from themost deprived
areas and that from the least deprived areas was esti-
mated on the assumption that 90% of participants
would attend both study visits and haveC reactive pro-
tein measured, and that a maximum of 10% would not
have a carotid ultrasound scan of satisfactory quality
formeasurement of intima-media thickness. Power cal-
culations were based on perceived clinically meaning-
ful differences between the two groups and assumed a
1.1 mg/l standard deviation for the natural logarithm
of C reactive protein measurements38 and a 0.163 mm
standard deviation for intima-media thickness.39 These
calculations indicated that a sample size of 350 per
group would provide 84% power to detect a 30%
difference in mean C reactive protein concentration
and 82% power to detect a 0.04 mm difference in
mean intima-media thickness.
Descriptive statistics are presented as mean (stan-
dard deviation) for continuous variables and count
(%) for categorical outcomes. Variables with positively
skewed distributions (triglycerides, C reactive protein,
interleukin 6, and intercellular adhesion molecule 1)
are described by geometric means and log transforma-
tion was used for regression analysis. For comparisons
of population characteristics between deprivation
groups, analysis of covariance was used for continuous
variables and logistic regression analyses for binary
responses. The results were presented as adjusted
means for “least” deprived minus “most” deprived
andodds ratios for least deprived versusmost deprived
categories, respectively. Cut-off points for logistic
regressionwere selected on the following basis: annual
income was categorised using the categories in the
Least deprived
(n=342)
Most deprived
(n=324)
Least minus most deprived
(adjusted for age and sex(95% CI)) P value
Data missing 7 (0) 14 (0)
Glucose (mmol/l) 5.15 (0.69) 5.42 (1.90) −0.41 (−0.69 to −0.14) 0.0088
Data missing 19 (7) 35 (16)
Weight (kg) 78.7 (15.3) 78.2 (18.4) 0.34 (−2.06 to 2.74) 0.78
Data missing 1 (0) 1 (0)
Waist/hip ratio 0.88(0.08) 0.92(0.09) −0.04 (−0.05 to −0.03) <0.0001
Data missing 3 (1) 4 (2)
BMI 26.9 (4.49) 28.7 (6.34) −1.81 (−2.64 to −0.98) <0.0001
Data missing 2 (0) 2 (0)
Blood pressure (mm Hg) 135 (17.8)/81.4 (10.3) 136 (20.0)/81.1 (11.6) −0.75 (−3.44 to 1.93)/0.27 (−1.32 to 1.87) 0.58/0.74
Data missing 2 (0) 2 (0)
Emerging risk factors: insulin resistance/fat mass
Insulin (mU/l) 6.62 (4.91) 7.72 (5.97) −1.81 (−3.29 to −0.34) 0.011
Data missing 18 (8) 41 (26)
Homeostasismodel of assessment-insulin resistance (HOMA-
IR)
1.52 (1.22) 1.81 (1.60) −0.80 (−1.15 to −0.44) 0.015
Data missing 24 (10) 49 (31)
Leptin (ng/ml) 18.7 (16.8) 23.7 (24.0) −4.46 (−7.24 to −1.67) 0.0017
Data missing 14 (0) 20 (0)
Emerging risk factors: inflammation/endothelial dysfunction
C reactive protein (mg/l) 1.16 2.07 −0.57 (−0.74 to −0.41)‡ <0.0001
Data missing 11 (4) 19 (5)
Interleukin 6 (pg/ml) 1.36 2.08 −0.43 (−0.53 to −0.33)‡ <0.0001
Data missing 13 (3) 24 (8)
Intercellular adhesion molecule 1 (ng/ml) 235.8 302.4 −0.25 (−0.29 to −0.21)‡ <0.0001
Data missing 10 (0) 20 (4)
Emerging risk factors: haemostasis
von Willebrand factor (IU/dl) 129 (39) 155 (47) −26 (−33 to −20) <0.0001
Data missing 8 (0) 23 (0)
Fibrinogen (g/l) 3.23 (0.60) 3.50 (0.80) −0.26 (−0.36 to −0.15) <0.0001
Data missing 10 (0) 23 (0)
D-dimer (ng/ml) 130 (97) 155 (102) −24 (−39 to −8.9) 0.0018
Data missing 8 (0) 23 (0)
Descriptive statistics are presented as mean (standard deviation) for continuous variables and count (%) for categorical outcomes. Geometric means are shown for triglycerides, C reactive
protein, interleukin 6, and intercellular adhesion molecule 1.
In “Data missing” fields, figures in brackets indicate the number of values that were removed on the basis of known pre-analytical factors or biological implausibility.
†Odds ratio.
‡Difference of logged parameters.
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original participant questionnaire, and plaque score
was classified according to a previously described
method.16 Point estimates, 95% confidence intervals,
and P values were calculated.
For intima-media thickness, an analysis was per-
formed of thickness versus age for men and women
in each deprivation category. Given that the slopes
and intercepts of the resulting plots differed between
the least deprived group and the most deprived
group, a 2 degrees of freedom F test was used. For ana-
lysis of plaque score, negative binomial regression was
carried out with additional adjustment for the number
of missing scans. For multivariate models involving
plaque, plaque presence was used as the dependent
variable and logistic regression was used for model-
ling. Missing values were removed from the relevant
analyses.
RESULTS
Overall, 2712 invitations to participatewere issued and
666 individuals completed both study visits, giving an
overall response rate of 24.6%. The least deprived
group thus comprised 175 men and 167 women, and
themost deprived group consisted of 159men and 165
women.Only 19 participants (2.9%)were born outside
the United Kingdom and the Republic of Ireland (14
from the least deprived group and five from the most
deprived group).
The response rate for the least deprived group was
33.9% and for the most deprived group was 19.0%.
When participants were stratified by deprivation cate-
gory (most deprived or least deprived), gender (male
or female), and age (35-44 years, 45-54 years, or
55-64 years), response rate varied from 13.6% in men
aged 35-44 years in the most deprived group to 51.2%
in men aged 55-64 years in the least deprived group.
Full details of response rates have been published
previously.33
Comparison of participants and non-participants
In order to compare the characteristics of individuals
who tookpart in the study and thosewhodid not, anon-
ymised data were extracted from the General Practice
Administration System for Scotland,40 which was used
by eight of the 10 practices from which participants
were drawn (four in the least deprived areas and four
in the most deprived areas). Data were obtained from
the database on smoking status and current prescrip-
tions for statins, aspirin, antihypertensives, anti-
depressants, and antidiabetic drugs. Data were
collected separately for individuals who attended visit
one (group one, n=700), those who declined to attend
Table 2 | Differences in ultrasound markers of atherosclerosis between participants from the
most deprived areas and those from the least deprived areas
Least
deprived
(n=342)
Most
deprived
(n=324)
Least minus most deprived
(adjusted for age and sex
(95% CI)) P value
Mean (SD) carotid intima-media
thickness (mm)
0.68 (0.12) 0.70 (0.16) −0.02 (−0.04 to −0.00) 0.015
Data missing 23 29
Mean (SD) plaque score 1.0 (1.5) 1.7 (2.0) <0.0001*
Number of plaques (%)
0 plaques 193 (56.9%) 130 (41.7%)
<0.0001
for trend*
1-2 plaques 101 (29.8%) 89 (28.5%)
>2 plaques 45 (13.3%) 93 (29.8%)
Data missing 3 12
*Not adjusted for age and sex.
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Fig 1 | Intima-media thickness by age tertile and deprivation category. LD=least deprived, MD=most deprived
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(group two, n=812), and those who did not respond to
the invitation (group three, n=1200). Non-participants
(group four, n=2012) were defined as the combination
of groups two and three.
In the least deprived group, more non-participants
than participants were current smokers (11.5% v 6.3%;
P=0.017). No such difference was observed in the most
deprived group (non-participants who were current
smokers 50.5% v participantswhowere current smokers
48.8%; P=0.6). Participants in both the least deprived
and most deprived group were more likely than non-
participants to be on statins (least deprived participants
8.8% v least deprived non-participants 5.0%; P=0.03;
most deprived participants 29.7% vmost deprived non-
participants 15.5%; P<0.0001), antihypertensives (least
deprived participants 18.2% v least deprived
non-participants 13.3%; P=0.05; most deprived
participants 34.8% v most deprived non-participants
24.5%; P=0.0004), and antidiabetic medications
(least deprived participants 2.8% v least deprived
non-participants 0.9%; P=0.03; most deprived
participants 8.5% v most deprived non-participants
5.0%; P=0.02).
Characteristics of the least deprived and most
deprived groups are shown in table 1. Of note is the
fact that the difference in total cholesterol between the
least deprived and most deprived groups was highly
statistically significant and the direction of difference
was the opposite of whatmight intuitively be expected:
total cholesterol was lower in the most deprived group
than in the least deprived group (4.95 mmol/l v
5.29 mmol/l; P<0.0001). High density lipoprotein
cholesterol was lower in the most deprived group
(1.30 mmol/l v 1.43 mmol/l; P<0.0001) as was low
density lipoprotein (2.86 mmol/l v 3.16 mmol/l;
P<0.0001), so the low density lipoprotein/high density
lipoprotein ratio did not differ between the two groups
(mean of 2.37 in both; P=0.91). The differences in lipo-
protein concentrations persisted after adjustment for
the use of lipid lowering therapy (21.3% of most
deprived participants and 5.3% of least deprived parti-
cipants were on statin therapy; adjusted P=0.049 for
total cholesterol and P=0.00025 for high density lipo-
protein).
Blood pressure did not differ between the two
groups, and, as expected, current smoking differed
considerably, with the proportion of current smokers
in the most deprived group significantly higher than
that in the least deprived group (40.4% v 6.1%).
Indices of insulin resistance and dysglycaemia (fast-
ing glucose and insulin concentrations, and Homeo-
stasis Model of Assessment [HOMA-IR]) and obesity
(waist/hip ratio, BMI, and leptin concentration) were
significantly higher in the most deprived group
(P<0.05 for all; table 1). The difference in adiponectin
concentration between the two groups was not signifi-
cant (data not shown).
Markers of chronic inflammation and endothelial
dysfunction (C reactive protein, interleukin 6, inter-
cellular adhesion molecule 1, and vonWillebrand fac-
tor)were significantly different between the twogroups
(all P<0.0001). Fibrinogen and D-dimer concentra-
tions were higher in the most deprived category
(P<0.0001 and P=0.0018, respectively), but no differ-
encewas observed in tissue plasminogenactivator anti-
gen concentration (P=0.18).
Carotid ultrasound analysis
Differences in ultrasoundmarkers of atherosclerosis are
shown in table 2. The age and sex adjusted difference in
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Fig 2 |Plaque score by age tertile and deprivation category. LD=least deprived, MD=most deprived
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mean intima-media thickness between the most
deprived group and the least deprived group was
0.02 mm (P=0.015). When analysing men and women
separately, the difference in mean intima-media
thickness between participants in most and least
deprived areas was statistically significant for men
(P=0.044) but not for women (P=0.77).
Figures 1 and 2 show the differences in carotid
intima-media thickness and plaque score for each gen-
der, separately split by age tertile. The ages stated for
each age tertile are the ages of the participants at the
time of carotid ultrasound scan, by which point the
participants were slightly older than they were at the
time of original selection for the study. The expected
increase in intima-media thickness with age is present;
however, the difference in intima-media thickness
between the most deprived group and the least
deprived group only reached statistical significance in
the highest age tertile (56.3-66.5 years) in men and did
not achieve statistical significance inwomen at any age.
By contrast, the difference in mean plaque score
between the most deprived group and the least
deprived group was highly significant in men in the
two highest age tertiles (46.8-56.2 years and 56.3-66.
5 years; P=0.0073 and P<0.001) and in women in the
highest age tertile (56.3-66.5 years; P<0.001).
Multivariate analyses for carotid intima-media thickness
As planned in the study protocol,33 analyses were car-
ried out to uncover potential explanations for the var-
iation in intima-media thickness according to area level
deprivation. Given that this difference was significant
only in men when the genders were analysed sepa-
rately, only men were included in these analyses.
The following variables listed in table 1 were signif-
icant correlates for age adjusted intima-media thick-
ness: log triglycerides (positive association;
P=0.0092); high density lipoprotein cholesterol (nega-
tive association; P=0.044); and systolic blood pressure
(positive association; P=0.028).Anumber ofmultivari-
atemodelswere then constructed,withpotential expla-
natory variables grouped according to category of risk
marker (for example, classic risk factors, markers of
insulin resistance, inflammatory markers, markers of
haemostasis) and adjusted for in the analyses. When
intima-media thickness was plotted against age, the
gradient (representing rate of increase in intima-
media thickness with age) differed between men from
the most and least deprived areas.
Table 3 shows the means and P values for the differ-
ences in the gradients of plots of mean common carotid
intima-media thickness against age for most deprived
and least deprived men, adjusted as described for each
model. In addition, the F test P value is also given to take
account of differential intercepts. Adjusting for the clas-
sic risk factors of age, triglycerides, low density lipopro-
tein cholesterol, high density lipoprotein cholesterol,
systolic blood pressure, diastolic blood pressure,
smoking, and history of hypertension (model 2) failed
to attenuate the difference in intima-media thickness
between most deprived men and least deprived men
(P=0.031).
In furthermodels, “emerging” risk factors represent-
ing insulin resistance, inflammatory factors, and hae-
mostasis were adjusted for. Additionally, models
incorporating physical activity and individual level
markers of socioeconomic status were constructed.
Finally, all variables were added simultaneously to a
model. With all classic and emerging risk factors
added, and individual level markers of socioeconomic
status included, the difference in intima-media thick-
ness between most deprived and least deprived males
remained significant (model 10; P=0.010).
Multivariate analyses for plaque score
On age and sex adjusted analyses, the following risk
factors were significant predictors of plaque presence:
log triglycerides (P=0.0016); systolic blood pressure
(P=0.0079); diastolic bloodpressure (P=0.049); current
Table 3 | Differences between men from the least deprived areas and those from the most
deprived areas in gradient of mean common carotid intima-media thickness plotted against
age
Gradient
F test P valueMean difference (95% CI) P value
Model 1 (unadjusted) −0.07 (−0.11 to −0.02) 0.0059 0.0011
Model 2
(classic risk factors)
−0.06 (−0.11 to −0.01) 0.021 0.031
Model 3
(classic+insulin resistance)
−0.07 (−0.12 to −0.02) 0.008 0.017
Model 4
(classic+inflammatory)
−0.06 (−0.11 to −0.01) 0.021 0.018
Model 5
(classic+haemostasis)
−0.06 (−0.11 to −0.01) 0.02 0.037
Model 6
(classic+physical activity)
−0.06 (−0.11 to −0.01) 0.018 0.026
Model 7
(classic+all “emerging”+physical
activity)
−0.08 (−0.13 to −0.02) 0.0075 0.010
Model 8
(classic+individual socioeconomic
status (early life))
−0.06 (−0.11 to −0.01) 0.024 0.053
Model 9
(classic+individual socioeconomic
status (all))
−0.07 (−0.12 to −0.02) 0.01 0.03
Model 10
(classic+all)
−0.1 (−0.16 to −0.03) 0.0025 0.010
Model 1: not adjusted for other factors.
Model 2 (classic risk factors): adjusted for triglycerides, low density lipoprotein cholesterol, high density
lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, smoking, and history of hypertension.
Model 3 (classic+insulin resistance markers): as Model 2+waist circumference, glucose, Homeostasis Model of
Assessment-Insulin Resistance (HOMA-IR), adiponectin, leptin, and history of diabetes.
Model 4 (classic+inflammatory): as Model 2+C reactive protein, interleukin 6, and intercellular adhesion
molecule 1.
Model 5 (classic+haemostasis): as Model 2+fibrinogen, D-dimer, and von Willebrand factor.
Model 6 (classic+physical activity): as Model 2+physical activity.
Model 7 (classic+all “emerging”+physical activity): as Model 2+ waist circumference, glucose, Homeostasis
Model of Assessment-Insulin Resistance, adiponectin, leptin, history of diabetes, C reactive protein, interleukin
6, intercellular adhesion molecule 1, fibrinogen, D-dimer, von Willebrand factor, and physical activity.
Model 8 (classic+individual socioeconomic status (early life)): as Model 2+height, leg length, people per room
at age 11 years, father’s Registrar General social class, and total years of education.
Model 9 (classic+individual socioeconomic status (all)): as Model 8+participant’s Registrar General social class
and annual household income.
Model 10 (classic+all): as Model 2+waist circumference, glucose, Homeostasis Model of Assessment-Insulin
Resistance, adiponectin, leptin, history of diabetes, C reactive protein, interleukin 6, intercellular adhesion
molecule 1, fibrinogen, D-dimer, von Willebrand factor, physical activity, height, leg length, people per room at
age 11 years, father’s Registrar General social class, participant’s Registrar General social class, annual
household income, and total years of education.
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smoking (P<0.0001); log intercellular adhesion mole-
cule 1 (P=0.00028); and fibrinogen (P=0.023). Height
(P=0.00013) and hip circumference (P=0.00014) were
inversely associated with plaque score.
Multivariate models were constructed using pre-
sence of plaque as the dependent variable. The ana-
lyses were run in all participants because plaque score
was significantly different between most deprived and
least deprived groups in bothmen andwomen. Plaque
presence rather than plaque score was used as the
dependent variable in these analyses because plaque
score did not fit conventional distributions that might
be used for regression analyses and it was decided that
the binary approach to transformation would encom-
pass most of the information in the data.
The results of multivariate analyses for plaque pre-
sence are shown in table 4. In the model that adjusted
for all classic and novel risk factors plus physical activ-
ity (model 7), the difference in plaque presence
between themost deprived and the least deprived indi-
viduals remained significant (adjusted odds ratio 1.73,
95% confidence interval 1.07 to 2.82; P=0.026). In gen-
eral terms, individuals from the most deprived areas
had around a 1.5-fold to 2-fold higher risk of plaque
presence than those from least deprived areas.
In contrast to the effect on intima-media thickness,
however, inclusion of individual level markers of early
life socioeconomic status (height, leg length, people
per room at age 11 years, father’s Registrar General
social class, and total years of education;model 8) abol-
ished the difference in plaque presence between indi-
viduals from the most deprived areas and those from
the least deprived areas (adjusted odds ratio for plaque
presence 0.94, 95% CI 0.54 to 1.65; P=0.84). When all
individual level markers of socioeconomic status
(height, leg length, people per room at age 11 years,
father’s Registrar General social class, participant’s
Registrar General social class, annual income, and
total years of education) were each added in turn to a
model, none of the individual level markers of socio-
economic status on their own abolished the area level
deprivation based difference in plaque presence (data
not shown).
DISCUSSION
This study examined the prevalence of carotid athero-
sclerosis in participants at extremes of the socioeco-
nomic gradient in Glasgow, a city whose inhabitants
have well documented health issues associated with
social deprivation. We found that carotid plaque
score and intima-media thickness were significantly
worse in participants from the bottom 5% of all areas
classed by the Scottish Index of Multiple Deprivation
than in individuals living in areas classified as being in
the top 20%. Although there were clear differences in
biomarkers of chronic inflammation between the par-
ticipants from the two groups, neither these factors nor
classic risk factors satisfactorily explained the
increased atherosclerosis burden in the lower socio-
economic status group. Adjusting for individual level
markers of socioeconomic status eliminated the area
level difference in plaque presence, although this
adjustment did not reduce the area level difference in
intima-media thickness.
A striking finding in this study is that a difference
between the two groups in plaque score appeared at
an earlier age than a difference in intima-media thick-
ness, although the trends in intima-media thickness are
as expected (rising with age; greater in males). The dif-
ference in intima-media thickness between partici-
pants from the least and most deprived areas did not
reach statistical significance inwomen at any age tertile
studied. This finding is not surprising given that the
difference in men only reached statistical significance
in the highest age tertile and the fact that atherosclero-
sis tends to develop around a decade later in women
than in men.
In contrast to intima-media thickness, differences in
plaque scorewere highly statistically significant, reach-
ing significance in the two highest age tertiles in men
and the highest age tertile in women. This observation
Table 4 | Adjusted odds ratios for plaque presence in individuals from the most deprived
areas versus those from the least deprived areas
Odds ratio (95% CI) P value
Model 1 (age, sex, scans present) 2.05 (1.45 to 2.89) <0.0001
Model 2
(classic risk factors)
1.71 (1.14 to 2.55) 0.009
Model 3
(classic+insulin resistance)
1.82 (1.18 to 2.80) 0.0066
Model 4
(classic+inflammatory)
1.71 (1.11 to 2.65) 0.015
Model 5
(classic+haemostasis)
1.77 (1.16 to 2.69) 0.0075
Model 6
(classic+physical activity)
1.60 (1.05 to 2.41) 0.027
Model 7
(classic+all “emerging”+physical activity)
1.73 (1.07 to 2.82) 0.026
Model 8
(classic+individual socioeconomic status (early
life))
0.94 (0.54 to 1.65) 0.84
Model 9
(classic+individual socioeconomic status (all))
1.12 (0.53 to 2.37) 0.76
Model 10
(classic+all)
1.05 (0.45 to 2.44) 0.91
Model 1: adjusted for age, sex, and scans present.
Model 2 (classic risk factors): adjusted for age, sex, scans present, triglycerides, low density lipoprotein
cholesterol, high density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, smoking,
and history of hypertension.
Model 3 (classic+insulin resistance markers): as Model 2+waist circumference, glucose, Homeostasis Model of
Assessment-Insulin Resistance (HOMA-IR), adiponectin, leptin, and history of diabetes.
Model 4 (classic+inflammatory): as Model 2+C reactive protein, interleukin 6, and intercellular adhesion
molecule 1.
Model 5 (classic+haemostasis): as Model 2+fibrinogen, D-dimer, and von Willebrand factor.
Model 6 (classic+physical activity): as Model 2+physical activity.
Model 7 (classic+all “emerging”+physical activity): as Model 2+ waist circumference, glucose, Homeostasis
Model of Assessment-Insulin Resistance, adiponectin, leptin, history of diabetes, C reactive protein, interleukin
6, intercellular adhesion molecule 1, fibrinogen, D-dimer, von Willebrand factor, and physical activity.
Model 8 (classic+individual socioeconomic status (early life)): as Model 2+height, leg length, people per room
at age 11 years, father’s Registrar General social class, and total years of education.
Model 9 (classic+individual socioeconomic status (all)): as Model 8+participant’s Registrar General social class
and annual household income.
Model 10 (classic+all): as Model 2+waist circumference, glucose, Homeostasis Model of Assessment-Insulin
Resistance, adiponectin, leptin, history of diabetes, C reactive protein, interleukin 6, intercellular adhesion
molecule 1, fibrinogen, D-dimer, von Willebrand factor, physical activity, height, leg length, people per room at
age 11 years, father’s Registrar General social class, participant’s Registrar General social class, annual
household income, and total years of education.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 9 of 12
suggests that plaque score measured in a standardised,
objective, and blinded way could show differences
between most deprived and least deprived individuals
more accurately than intima-media thickness because
plaque score may be more sensitive in detecting ather-
osclerosis.
On multivariate analysis, adjusting for classic
risk factors reduced but did not abolish the
deprivation based difference in plaque presence and
intima-media thickness, strongly suggesting that classic
risk factors do not fully explain the difference in ultra-
sound markers of atherosclerosis between participants
from most and least deprived areas.
Inflammatory pathways are involved in
atherosclerosis,41 and significant differences in
inflammatory markers were noted between deprivation
categories in this study and in other studies.42 Thus, the
inclusion of markers of inflammation or endothelial
dysfunction might have been expected to reduce or
abolish the significant difference in plaque score. How-
ever, none of the measured markers of inflammation,
insulin resistance, or haemostasis had a significant
impact on the difference in plaque presence between
the two deprivation groups, with area level deprivation
remaining a significant predictor even once all classic
and emerging risk factors were included in the model.
These findings are consistent with those from the
Women’sHealth Study, inwhich the inverse association
between educational attainment and risk of cardio-
vascular events was not reduced by adjusting for
C reactive protein, intercellular adhesion molecule 1,
fibrinogen, or homocysteine.43
Only by adjusting for individual level markers of
socioeconomic status was the difference in plaque pre-
sence between participants from the least and most
deprived areas abolished. Even this adjustment did
not explain the deprivation based difference in
intima-media thickness in males. Given that area
level and individual level markers of socioeconomic
status are likely to be highly correlated, it is clearly
plausible that the abolitionof the area level deprivation
based difference in plaque presence on adjusting for
individual level markers of socioeconomic status
might be the result of overadjustment.
It would be of interest to know whether assessment
of plaque volume would yield further useful
information,44 but the technology allowing such assess-
ment is not yet widely available.
Strengths and limitations of study
Several strengths of this study are worthy of comment.
Participants were selected on the basis of area level
deprivation category as classified by the Scottish
Index of Multiple Deprivation, rather than the effects
of socioeconomic status being examined post hoc. The
setting of Glasgow, Scotland, is excellent for such a
study because a wide range of deprivation and life
expectancy can be foundwithin the city. The complete
dataset, with relatively few missing results, is also a
strength of this study.
Limitations of this study include the fact that only
individuals from the two extremes of area level social
deprivation were included. Social deprivation exists as
a continuum, and it could be argued that a full under-
standing of the effects of deprivation cannot be
achieved by studying only individuals at the two
extremes. We decided for practical purposes, and
also to maximise the opportunity to identify differ-
ences between most and least deprived populations,
that a study design looking at the two extremes of
deprivation was appropriate.
Anotherconcernof this study is thequestionofwhether
study participants differed from non-participants. In
particular, it is possible that the “worried well” and the
“healthy deprived” would preferentially volunteer for
this study, thus minimising potential differences between
least andmostdeprivedcommunities.Ourcomparisonof
study participants with individuals in the anonymised
data obtained from the General Practice Administration
System for Scotland demonstrated differences between
participants andnon-participants.We foundhigher levels
of prescriptions for statins, antihypertensives, and
antidiabetic drugs in participants compared with
non-participants, especially in the most deprived group,
which implies that those who participated had a higher
level of recognised morbidity than those who did not
participate. In addition, such individuals were probably
more concerned about their health or were more used to
visiting their general practitioner.
A further concern could be raised regardingwhether
the findings from this study are generalisable to popu-
lations other than those living in the NHS Greater
Glasgow area. Ongoing research by the GlasgowCen-
tre for Population Health, however, suggests that cur-
rent levels (and distributions) of socioeconomic
deprivation in Glasgow are almost identical to those
seen in Liverpool and inManchester (Glasgow Centre
for Population Health, unpublished data). Thus, the
deprivation profile of Glasgow is not unique in the
WHAT IS ALREADY KNOWN ON THIS TOPIC
Coronary heart disease is more prevalent in areas of relative social deprivation than in
socioeconomically advantaged areas
This health gap is not satisfactorily explained by currently recognised (“classic”)
cardiovascular risk factors
A number of novel (“emerging”) risk factors have been identified that might contribute to
deprivation based differences in cardiovascular disease
WHAT THIS STUDY ADDS
Indices of atherosclerosis (carotid intima-media thickness and plaque presence), as
determined by ultrasound, are significantly higher in people frommore deprived areas;
plaque score being the more sensitive marker
Adjustment for classic cardiovascular risk factors and emerging risk factors associated with
insulin resistance, inflammation, endothelial dysfunction, and haemostasis does not abolish
the deprivation based difference in ultrasound markers of atherosclerosis
Adjustment for individual level markers of socioeconomic status as well as classic and
emerging risk markers likewise does not abolish the difference in carotid intima-media
thickness between men from the least deprived areas and those from the most deprived
areas
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context of other post-industrial cities in the United
Kingdom.
Conclusions and policy implications
This study demonstrates the great significance of area
level socioeconomic deprivation as a predictor of
atherosclerosis. Classic cardiovascular risk factors did
not fully explain the difference in plaque presence
between participants from the most deprived areas
and those from the least deprived areas, suggesting
that current public health messages directed at classic
risk factors (diet, blood pressure, smoking) may not
adequately address the continuing socioeconomic gra-
dient in cardiovascular disease. The findings in this
study add weight to the case for inclusion of social
deprivation in cardiovascular risk assessment, as has
been done in the ASSIGN (ASSessing cardiovascular
risk using SIGN) scoring system.45
Although the deprivation based difference in ather-
osclerosis was not explained by the classic risk factors
examined, neither was it explained by the range of
emerging markers measured in this study. Health sta-
tus is a reflection not only of features of the individual
but also of wider social and economic influences,
health and social services, early life experiences, and
environmental factors. The analyses reported here
focused on biological pathways that might explain
the disparity (for example, insulin resistance, inflam-
mation, and haemostasis). Further analyses focusing
on the relative strengths of different pathways in
explaining the health gap between the most and least
deprived participants may help in unravelling the
multifactorial nature of health inequalities.
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